In the dynamic field of pharmaceutical research, the quest for novel therapeutic agents with well-defined mechanisms of action is continuous. Among the myriad of natural compounds, Chelerythrine stands out as a particularly promising benzophenanthridine alkaloid. Sourced from plants like Macleaya cordata, this compound, with CAS number 34316-15-9, has garnered significant attention for its potent and selective inhibition of Protein Kinase C (PKC).

PKC plays a pivotal role in numerous cellular signaling pathways, including cell proliferation, differentiation, and apoptosis. By targeting PKC, Chelerythrine offers a powerful tool for scientists investigating a wide range of diseases, particularly cancers. Its ability to induce apoptosis, a programmed cell death mechanism essential for eliminating cancerous cells, has positioned it as a key candidate for anticancer drug development. Research indicates its efficacy against various cancer cell lines, making it a valuable intermediate for pharmaceutical companies looking to buy novel drug candidates.

Beyond its well-documented role in cancer research, Chelerythrine also exhibits notable antibacterial and anti-inflammatory properties. This multifaceted bioactivity spectrum makes it an attractive compound for a broader range of therapeutic applications, from developing new antibiotics to anti-inflammatory treatments. As a dedicated manufacturer, we understand the critical need for high-purity compounds in research. Therefore, we ensure that our Chelerythrine is supplied at a minimum purity of 98%, providing reliability for your critical experiments.

For procurement managers and research scientists seeking to integrate cutting-edge natural compounds into their workflow, understanding the sourcing and quality is paramount. As a leading supplier in China, NINGBO INNO PHARMCHEM CO.,LTD. is committed to providing consistent quality and reliable supply. We encourage you to inquire about our price and availability to secure this valuable research chemical for your next project. Partner with us to drive your pharmaceutical innovation forward.